Indication
Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
1 clinical trial
2 products
Product
OPS-2071Product
placeboClinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled, Clinical Trial to Evaluate the Efficacy and Safety of Different Doses of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type (IBS-D)Status: Recruiting, Estimated PCD: 2024-08-01